ecancer

New approaches and new partnership models for biomarker based clinical research

Dr Denis Lacombe, EORTC, Brussels, Belgium

6 Jan 2015

The DNA damage response and cancer therapy

Dr Christopher Lord, The Institute of Cancer Research, London, UK

6 Jan 2015

Aims and successes of the 2nd EurocanPlatform project translational research course

Christina von Gertten, Karolinska Institutet, Stockholm, Sweden

6 Jan 2015

Epigenome deregulation in cancer

Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, France

6 Jan 2015

Immunotherapy of cancer: recent progress and future challenges

Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden

6 Jan 2015

Reasons to attend the EurocanPlatform translational research course 2015

Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany

6 Jan 2015

Biobanking biological materials and linkage to clinical information

Dr Peter Riegman, Erasmus Medical Center, Rotterdam, The Netherlands

6 Jan 2015

The role of health economics in cancer outcomes research

Prof Bengt Jönsson, Stockholm School of Economics, Stockholm, Sweden

6 Jan 2015

Effects of aspirin on cancer outcomes

Prof Peter Rothwell - University of Oxford, Oxford, UK

19 Dec 2014

Hip fracture complications of prostate cancer treatment

Sara Faithfull - University of Surrey, Guildford, UK

$Hip fracture complications of prostate cancer treatment ( Sara Faithfull - University of Surrey, Guildford, UK )$

7 Nov 2014

Cancer screening complications in the elderly

Prof Vesa Kataja - Kuopio University Hospital, Kuopio, Finland

7 Nov 2014

ecancermedicalscience editor's choice for October 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

30 Oct 2014

More from ecancer